一、本激励计划已履行的决策程序 年限制性股票激励计划（草案）>及其摘要的议案》 证券代码：002516 证券简称：旷达科技 公告编号：2025-022 旷达科技集团股份有限公司关于 提示性公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整， 没有虚假记载、误导性陈述或重大遗漏。 特别提示： 划》（以下简称"本激励计划"）第一个解除限售期解除限售条件已经成就，本次符合 解除限售条件的激励对象共计7名，可解除限售的限制性股票数量为524.00万股，占 公司当前总股本的0.3563%。 《关于 <公司2024年限制性股票激励> 计划实施考核管理办法>的议案》及《关于提请股东大会授权董事会办理股权激励相关 事宜的议案》，独立财务顾问及律师出具了相应的报告和法律意见书。 年限制性股票激励计划（草案）>及其摘要的议案》 《关于 <公司2024年限制性股票激励> 计划实施考核管理办法>的议案》及《关于核实 <公司2024年限制性股票激励计划对象> 名单>的议案》。 务在公司官网进行了公示，公司员工可在公示期限内向监事会提出反馈意见，截至公 示期满公司监事会未收到任何组织或个人对本激励计划拟激励对象提出的异议。2 ...

Core Viewpoint - The company conducted a self-examination regarding insider trading activities related to its 2025 Restricted Stock Incentive Plan, confirming no violations occurred during the specified period [1][2][3]. Summary by Sections Insider Trading Self-Examination - The company reviewed insider trading activities of individuals aware of the 2025 Restricted Stock Incentive Plan during the six months prior to its public disclosure, from December 20, 2024, to June 20, 2025 [2]. - Two individuals classified as insider information knowers engaged in stock trading during this period, but their actions were based solely on personal market analysis, without knowledge of the incentive plan details [2][3]. Stock Buyback Activities - During the self-examination period, the company repurchased a total of 1,740,800 shares through a dedicated securities account via centralized bidding, adhering to legal disclosure requirements [3]. - The company confirmed that no insider information was utilized for trading during the stock buyback process [3]. Compliance and Conclusion - The company followed relevant laws and internal confidentiality protocols, ensuring that only a limited number of individuals participated in discussions regarding the incentive plan [3]. - The examination concluded that no insider trading or information leakage occurred related to the 2025 incentive plan, aligning with regulatory requirements [3].

Core Points - The company has announced the results of the first vesting period for the 2024 restricted stock incentive plan, with a total of 1.50% of the company's total shares being granted at a price of 3.58 yuan per share [1][2][3] - A total of 1,717,000 shares were granted, representing 4.28% of the company's total shares at the time of the announcement, with 1,597,000 shares granted in the first round [2][3] - The vesting conditions include performance targets based on net profit growth over three years, with specific thresholds set for each vesting period [4][5] Incentive Plan Details - The incentive plan was approved by the board and supervisory committee, and the first grant was made on July 1, 2024, to 167 individuals [6][7] - The vesting schedule includes three periods: 40% after 12 months, 30% after 24 months, and 30% after 36 months [3][4] - The performance assessment for the first vesting period requires a net profit of at least 17.5 million yuan for 2024, which is a growth from the 2023 net profit of 7,814.16 million yuan [4][15] Shareholder Impact - Following the vesting, the total number of shares will increase from 567,068,743 to 571,982,940, with a minor impact on earnings per share [16][17] - The funds raised from the share issuance will be used to supplement the company's working capital [16] Legal and Financial Advisory - The company has obtained necessary approvals and authorizations for the incentive plan, ensuring compliance with relevant regulations [18] - Independent financial advisors have confirmed that the vesting conditions have been met and that the plan does not harm the interests of the company or its shareholders [18]

登录新浪财经APP 搜索【信披】查看更多考评等级 长江商报消息 ●长江商报记者 黄聪 上市公司掌门人被留置调查又添一人。 7月6日晚间，新里程（002219.SZ）公告显示，公司董事长林杨林被太原市小店区监察委员会实施留置 并立案调查。 资料显示，林杨林1981年出生，2021年3月起成为新里程董事长，是一名80后掌门人。 林杨林上任后扭转了新里程持续亏损局面，但业绩也并不稳定。 2022年12月，新里程发布了2022年限制性股票激励计划（草案），2023年至2025年，公司力争营业收入 分别为35.4亿元、41.1亿元和49亿元。 2023年，新里程营业收入达39.14亿元，完成目标。但2024年，公司营业收入下降2.95%，没有完成业绩 考核目标。 长江商报记者发现，要完成2025年目标，新里程营业收入增速必须要达到约29%。 然而，2025年一季度，新里程实现营业收入7.96亿元，同比下降16.49%；净利润2565.19万元，同比下 降9.35%。公司出现业绩"双降"，全年营业收入目标难期。 2021年3月底，新里程董事会同意选举林杨林为公司第五届董事会董事长，任期至第五届董事会届满之 日止。 林杨林 ...

证券代码：688368 证券简称：晶丰明源 公告编号：2025-051 上海晶丰明源半导体股份有限公司 监事会关于公司 2025 年限制性股票激励计划 首次授予激励对象名单的审核意见及公示情况说明 本公司监事会及全体监事保证公告内容不存在任何虚假记载、误导性陈述或 者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 上海晶丰明源半导体股份有限公司（以下简称"公司"）于 2025 年 6 月 26 一、公示情况 （1）公司于 2025 年 6 月 27 日在上海证券交易所网站（www.sse.com.cn） 上披露了《上海晶丰明源半导体股份有限公司 2025 年限制性股票激励计划（草 案）》《上海晶丰明源半导体股份有限公司 2025 年限制性股票激励计划实施考核 管理办法》及《上海晶丰明源半导体股份有限公司 2025 年限制性股票激励计划 首次授予激励对象名单》（以下简称"《激励对象名单》"）。 （2）公司于 2025 年 6 月 27 日至 2025 年 7 月 6 日在公司内部对本次拟激励 对象的姓名和职务进行了公示，公示时间共 10 天，公司员工可在公示期限内向 监事会提出反馈意见。 至公示 ...

Core Points - The company has adjusted the number and exercise price of its 2024 stock option incentive plan due to the implementation of its annual profit distribution plan [9][12] - The adjusted exercise price is set at 7.80 yuan per share, down from the previous 11.13 yuan per share [11][12] - The total number of stock options granted but not yet exercised has increased from 1,418,566 to approximately 1,974,595 [11][12] Summary by Sections Incentive Plan Overview - The incentive plan targets employees, middle management, and key personnel who directly impact the company's performance and future development [1] - The total number of stock options granted under this plan is 240,000, accounting for 1.88% of the company's total share capital [2] Adjustment Details - The adjustment was made following the company's profit distribution plan, which includes a cash dividend of 2.814904 yuan per 10 shares and a capital increase of 0.3919658 shares per 10 shares [9][10] - The adjustment methods for stock options include increasing the number of options based on capital increases and adjusting the exercise price based on dividends [10][11] Performance Assessment - The performance assessment for the stock options is based on net profit growth targets, with a minimum growth rate of 300% for 2024 and 500% for 2025 [4] - The assessment will determine the percentage of options that can be exercised based on the company's performance [4][5] Legal and Compliance - The adjustments have been reviewed and approved by the company's board and supervisory committee, ensuring compliance with relevant laws and regulations [12][13] - Legal opinions confirm that the necessary approvals and authorizations for the adjustments have been fulfilled [12]

Core Viewpoint - The supervisory board of Jinhe Biotechnology Co., Ltd. has reviewed and approved the conditions for the release of restricted stock under the 2023 Restricted Stock Incentive Plan, confirming compliance with relevant laws and regulations [1][3]. Summary by Sections Section 1: Review of Incentive Objects - The company meets the conditions for implementing the stock incentive plan as per the Management Measures and relevant regulations, confirming the eligibility of the incentive objects for the second release period and the first reserved grant period [1][2]. - The incentive objects for the current plan do not fall under any disqualifying conditions as outlined in the Management Measures [2]. Section 2: Approval of Release Conditions - The supervisory board has verified that the 70 initial incentive objects and 11 reserved incentive objects meet the conditions for the release of restricted stocks, with a total of 4,326,000 shares for the initial grant and 500,000 shares for the reserved grant approved for release [3]. Section 3: Repurchase and Cancellation of Restricted Stocks - The supervisory board has determined that 43 incentive objects did not fully meet performance targets, leading to the repurchase and cancellation of their unvested restricted stocks, totaling 2,100,000 shares [3][5]. - The repurchase price adjustment and the process for cancellation have been confirmed to comply with relevant regulations, ensuring no harm to the company or shareholders [4][5].

Core Viewpoint - The legal opinion letter from Beijing Zhonglun (Shanghai) Law Firm confirms the completion of the second unlock period for the initial grant of restricted stock and the first unlock period for reserved grants under the 2023 Restricted Stock Incentive Plan of Jinhe Biotechnology Co., Ltd, along with the repurchase and cancellation of certain restricted stocks and adjustments to the repurchase price [1][2][22]. Group 1: Unlock Conditions and Achievements - The second unlock period for the initial grant of restricted stocks is set to be 24 months after the registration completion date, which was completed on July 7, 2023 [13][14]. - The first unlock period for reserved grants is 12 months after the registration completion date, which was completed on December 28, 2023 [14]. - The company has met the performance assessment requirements for the unlock conditions, with a net profit growth rate of 88.29% in 2024, exceeding the required 78% [17][18]. Group 2: Repurchase and Price Adjustment - The company plans to repurchase and cancel a total of 2,100,000 shares of restricted stock due to the departure of certain incentive targets and performance failures [21][22]. - The adjusted repurchase price for the restricted stocks is set at 2.29 yuan per share, following a cash dividend distribution of 1.00 yuan per 10 shares [19][22]. - The repurchase will be funded by the company's own funds, and the repurchase reasons, quantity, price, and funding sources comply with relevant regulations [22].

Core Viewpoint - The company has announced the achievement of conditions for the first unlock period of the reserved stock grant and the second unlock period of the initial stock grant under the 2023 restricted stock incentive plan, allowing 71 incentive recipients to unlock a total of 4,826,000 shares, which represents 0.63% of the company's total share capital [1][2][18]. Summary by Relevant Sections Incentive Plan Overview - The 2023 restricted stock incentive plan initially granted 21,370,000 shares, accounting for approximately 2.74% of the company's total share capital at the time of the plan's announcement [2][11]. - The plan includes a reserved grant of 1,000,000 shares, representing 0.13% of the total share capital [2][11]. Unlock Conditions - A total of 71 incentive recipients are eligible for unlocking, with 70 recipients eligible for the second unlock period of the initial grant (4,326,000 shares) and 11 recipients eligible for the first unlock period of the reserved grant (500,000 shares) [1][2][18]. - The unlocking of shares is subject to the completion of necessary procedures by relevant authorities [1][2]. Performance Assessment - The performance assessment for the first unlock period requires a net profit growth rate of no less than 155% for 2023, based on the 2022 net profit [7][9]. - For the second unlock period, the required growth rate is 78% for 2024, and for the third unlock period, it is 131% for 2025 [9][10]. Compliance and Approval - The board of directors and the supervisory board have reviewed and approved the unlocking conditions, confirming compliance with relevant regulations and the company's articles of association [22][23]. - Legal opinions affirm that the necessary approvals and authorizations have been obtained for the unlocking of shares [24][25].

证券代码：300627 证券简称：华测导航 公告编号：2025-061 上海华测导航技术股份有限公司 本公司及监事会全体成员保证信息披露的内容真实、准确、完整，没有虚假 记载、误导性陈述或重大遗漏。 一、监事会会议召开情况 上海华测导航技术股份有限公司（以下简称"公司"）第四届监事会第十七 次会议的通知于2025年7月2日以书面或电子邮件的形式发出，会议于2025年7月 合通讯方式召开。本次会议应出席监事3名，实际出席监事3名。本次会议由沈礼 伟先生主持，公司部分高级管理人员列席了本次会议。 本次会议的召开和表决程序符合《中华人民共和国公司法》等有关法律、行 政法规、部门规章、规范性文件和《上海华测导航技术股份有限公司章程》的规 定。 二、监事会会议审议情况 经与会监事审议，以记名投票表决方式通过如下议案： 股票激励计划授予数量和授予价格》的议案。 经公司第四届监事会全体监事审议，一致认为公司2024年年度权益分派已于 法规、规范性文件和公司《2021年限制性股票激励计划（草案）》的规定，对2021 年限制性股票激励计划限制性股票的授予数量和授予价格进行调整，符合公司和 全体股东的利益，不存在损害中小股东合法 ...